Amgen Inc.
AMGN
$269.25
-$2.80-1.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.61% | 11.27% | 24.48% | 20.32% | 21.76% |
| Total Other Revenue | -16.11% | 1.93% | -0.85% | 14.52% | 27.03% |
| Total Revenue | 9.43% | 10.86% | 23.18% | 20.07% | 21.98% |
| Cost of Revenue | 3.91% | -71.01% | 83.28% | 78.49% | 45.76% |
| Gross Profit | 12.23% | 45.89% | 1.88% | -0.41% | 12.66% |
| SG&A Expenses | -6.69% | 5.09% | 20.10% | 37.94% | 43.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.92% | 108.35% | -91.91% | -101.90% | -- |
| Total Operating Expenses | 1.98% | -12.40% | 28.24% | 49.50% | 41.11% |
| Operating Income | 33.62% | 47.23% | 9.61% | -27.77% | -15.32% |
| Income Before Tax | 3,001.47% | -8.22% | 59.27% | -50.81% | -101.98% |
| Income Tax Expenses | 440.00% | 82.35% | 24.88% | -79.57% | -92.51% |
| Earnings from Continuing Operations | 1,630.97% | -18.25% | 63.58% | -45.90% | -103.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,630.97% | -18.25% | 63.58% | -45.90% | -103.98% |
| EBIT | 33.62% | 47.23% | 9.61% | -27.77% | -15.32% |
| EBITDA | 18.31% | 35.04% | 24.59% | -6.61% | 6.13% |
| EPS Basic | 1,625.43% | -18.55% | 62.98% | -46.10% | -103.96% |
| Normalized Basic EPS | 46.66% | 74.76% | -14.42% | -38.49% | -35.13% |
| EPS Diluted | 1,618.03% | -18.73% | 62.11% | -46.30% | -103.99% |
| Normalized Diluted EPS | 45.85% | 74.77% | -14.74% | -38.72% | -34.64% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% |
| Average Diluted Shares Outstanding | 0.93% | 0.37% | 0.74% | 0.74% | -0.37% |
| Dividend Per Share | 5.78% | 5.63% | 5.63% | 5.63% | 5.63% |
| Payout Ratio | 1.07% | 0.29% | -0.35% | 0.96% | -27.71% |